THORLNC |
|
testis associated oncogenic lncRNA
|
|
|
0.716 |
0.308 |
RGPD2 |
P0DJD1
|
RANBP2 like and GRIP domain containing 2
|
|
1.4E-03 |
0.695 |
0.346 |
AGFG2 |
O95081
|
ArfGAP with FG repeats 2
|
|
2.5E-04 |
0.700 |
0.423 |
WWTR1 |
Q9GZV5
|
WW domain containing transcription regulator 1
|
Enzyme modulator
|
0.94 |
0.529 |
0.615 |
CEMIP |
Q8WUJ3
|
cell migration inducing hyaluronidase 1
|
|
4.4E-17 |
0.617 |
0.615 |
SOX17 |
Q9H6I2
|
SRY-box transcription factor 17
|
Transcription factor
|
0.88 |
0.555 |
0.615 |
CDC73 |
Q6P1J9
|
cell division cycle 73
|
|
1.00 |
0.543 |
0.615 |
MIR613 |
|
microRNA 613
|
|
|
0.608 |
0.615 |
KRT8 |
P05787
|
keratin 8
|
|
2.4E-08 |
0.517 |
0.654 |
ZHX2 |
Q9Y6X8
|
zinc fingers and homeoboxes 2
|
Transcription factor
|
3.4E-02 |
0.510 |
0.654 |
DDX5 |
P17844
|
DEAD-box helicase 5
|
|
1.00 |
0.592 |
0.692 |
MYB |
P10242
|
MYB proto-oncogene, transcription factor
|
|
0.82 |
0.490 |
0.692 |
UHRF1 |
Q96T88
|
ubiquitin like with PHD and ring finger domains 1
|
|
|
0.540 |
0.692 |
CA9 |
Q16790
|
carbonic anhydrase 9
|
|
1.3E-09 |
0.483 |
0.731 |
CEACAM3 |
P40198
|
CEA cell adhesion molecule 3
|
|
1.1E-09 |
0.494 |
0.731 |
PSG2 |
P11465
|
pregnancy specific beta-1-glycoprotein 2
|
|
1.4E-30 |
0.492 |
0.731 |
LOC110806263 |
|
TERT 5' regulatory region
|
|
|
0.464 |
0.731 |
CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
CEACAM7 |
Q14002
|
CEA cell adhesion molecule 7
|
|
1.3E-07 |
0.494 |
0.769 |
IFI27 |
P40305
|
interferon alpha inducible protein 27
|
|
1.1E-02 |
0.437 |
0.769 |
IGFBP2 |
P18065
|
insulin like growth factor binding protein 2
|
Enzyme modulator
|
0.12 |
0.478 |
0.769 |
IRS1 |
P35568
|
insulin receptor substrate 1
|
|
2.4E-02 |
0.488 |
0.769 |
S100A4 |
P26447
|
S100 calcium binding protein A4
|
Calcium-binding protein
|
6.2E-03 |
0.448 |
0.769 |
SLC5A5 |
Q92911
|
solute carrier family 5 member 5
|
Transporter
|
2.9E-03 |
0.499 |
0.769 |
TP63 |
Q9H3D4
|
tumor protein p63
|
Transcription factor
|
1.00 |
0.362 |
0.769 |